Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by NeurAxis, Inc.
NeurAxis Announces Geisinger Health Plan Medical Policy Coverage for PENFS, Effective September 15 2024
August 27, 2024
From
NeurAxis, Inc.
Via
GlobeNewswire
NeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, effective October 1st 2024
August 13, 2024
From
NeurAxis, Inc.
Via
GlobeNewswire
NeurAxis Reports Second Quarter 2024 Financial Results
August 09, 2024
From
NeurAxis, Inc.
Via
GlobeNewswire
NeurAxis to Host Second Quarter 2024 Results and Business Update Call on Friday, August 9, 2024
August 05, 2024
From
NeurAxis, Inc.
Via
GlobeNewswire
NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit Disclosure
June 07, 2024
From
NeurAxis, Inc.
Via
GlobeNewswire
NeurAxis Reports First Quarter 2024 Financial Results
May 22, 2024
From
NeurAxis, Inc.
Via
GlobeNewswire
NeurAxis to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
May 21, 2024
From
NeurAxis, Inc.
Via
GlobeNewswire
NeurAxis Announces New Medical Policy Coverage For Nearly Six Million Lives in Florida
May 16, 2024
From
NeurAxis, Inc.
Via
GlobeNewswire
NeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesday, May 22, 2024
May 15, 2024
From
NeurAxis, Inc.
Via
GlobeNewswire
NeurAxis Announces New Medical Policy Coverage in North Dakota
April 23, 2024
From
NeurAxis, Inc.
Via
GlobeNewswire
NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial Results
April 09, 2024
From
NeurAxis, Inc.
Via
GlobeNewswire
NeurAxis to Host Fourth Quarter and Full Year 2023 Results and Business Update Call on Tuesday, April 9, 2024
April 01, 2024
From
NeurAxis, Inc.
Via
GlobeNewswire
NeurAxis Announces IB-Stim Results from a Large, Pediatric, Multi-Center Registry
March 27, 2024
From
NeurAxis, Inc.
Via
GlobeNewswire
NeurAxis Announces Highmark BCBS Policy Coverage
March 11, 2024
From
NeurAxis, Inc.
Via
GlobeNewswire
NeurAxis Announces Blue Cross and Blue Shield of Kansas City Policy Coverage
March 04, 2024
From
NeurAxis, Inc.
Via
GlobeNewswire
NeurAxis to Present at Oppenheimer 34th Annual Healthcare MedTech & Services Conference
February 27, 2024
From
NeurAxis, Inc.
Via
GlobeNewswire
NeurAxis Appoints Timothy Henrichs as Chief Financial Officer
January 31, 2024
From
NeurAxis, Inc.
Via
GlobeNewswire
NeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive Officer
December 20, 2023
From
NeurAxis, Inc.
Via
GlobeNewswire
NeurAxis Reports Third Quarter 2023 Financial Results
November 20, 2023
From
NeurAxis, Inc.
Via
GlobeNewswire
NeurAxis Announces CareFirst BCBS Policy Coverage
November 15, 2023
From
NeurAxis, Inc.
Via
GlobeNewswire
NeurAxis Secures $3 Million Financing
November 14, 2023
From
NeurAxis, Inc.
Via
GlobeNewswire
NeurAxis Signs Exclusive Option Agreement with University of Michigan for Innovative Gastrointestinal Device
November 08, 2023
From
NeurAxis, Inc.
Via
GlobeNewswire
NeurAxis Announces Results of Comparative Study of IB-Stim™ and Standard Medical Therapy in Adolescents with Functional Abdominal Pain Disorders
September 26, 2023
From
NeurAxis, Inc.
Via
GlobeNewswire
NeurAxis Reports Second Quarter 2023 Financial Results
September 21, 2023
From
NeurAxis, Inc.
Via
GlobeNewswire
NeurAxis to Present at the Gilmartin Group Emerging Growth Showcase
September 13, 2023
From
NeurAxis, Inc.
Via
GlobeNewswire
NeurAxis Announces Publication of Prospective Study Showing IB-Stim™ Improves Quality of Life of Adolescents with IBS
September 12, 2023
From
NeurAxis, Inc.
Via
GlobeNewswire
NeurAxis Highlights Pediatric Post-Concussion Clinical Study
August 29, 2023
From
NeurAxis, Inc.
Via
GlobeNewswire
NeurAxis Highlights Strength of its Board of Directors
August 24, 2023
From
NeurAxis, Inc.
Via
GlobeNewswire
NeurAxis Highlights Two Independent Studies Showing Benefits of IB-Stim in Adolescents Involving the Gut Microbiome
August 22, 2023
From
NeurAxis, Inc.
Via
GlobeNewswire
NeurAxis Announces Over $8 Million in IB-Stim™ Revenue
August 17, 2023
From
NeurAxis, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.